VanEck Pharmaceutical ETF (PPH)
NasdaqGM • Currently down 0.55 (-0.48%) in today's trading session
1 member of Congress has disclosed 2 trades in VanEck Pharmaceutical ETF (PPH) via STOCK Act filings. The most recent disclosure was a sale by Bruce Westerman on 28 May 2025. Aggregate disclosed activity totals roughly $8K in purchases and $32.5K in sales (midpoint estimates from bracketed disclosure amounts).
VanEck Pharmaceutical ETF is currently trading at $113.51, positioned at 86% of its 52-week range ($85.91 – $118.00).
Want to automatically copy Pelosi trades?
Mirror Nancy Pelosi's portfolio with just one click on eToro.
Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.
Past Performance is not an indication of future results.
VanEck Pharmaceutical ETF Price History and Technical Analysis
Congressional Trading Activity for PPH
| No data | |||||||
Select transactions to view their annotations on the chart
Similar Stocks
Based on congressional trading patterns
Frequently Asked Questions about PPH
- Which members of Congress have traded PPH?
- 1 member of Congress has disclosed 2 trade in VanEck Pharmaceutical ETF (PPH) under the STOCK Act: Bruce Westerman.
- When was PPH most recently disclosed by Congress?
- The most recent PPH disclosure was a sale by Bruce Westerman on 28 May 2025.
- What is the total disclosed congressional trading volume for PPH?
- Members of Congress have disclosed approximately $8K in PPH purchases and $32.5K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
- How can I track new congressional trades in PPH?
- This PPH page updates as soon as new STOCK Act disclosures are filed for VanEck Pharmaceutical ETF. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Track PPH in Congress
See when politicians buy or sell this stock